Remimazolam brings a new level of precision and predictability to benzodiazepine-based anesthesia. This course examines its mechanism as a GABAA receptor agonist, ultra-short-acting pharmacokinetics, and non-cumulative profile—highlighting where it outperforms traditional agents like midazolam in both procedural sedation and general anesthesia. You’ll also explore key drug interactions, including CNS depressants and CYP3A4 modulators, so you can safely integrate remimazolam into practice, especially for patients needing rapid recovery or with organ dysfunction.